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R E V I E W
Systematic Review of Studies Using Conjoint 
Analysis Techniques to Investigate Patients’ 
Preferences Regarding Osteoarthritis Treatment
This article was published in the following Dove Press journal: 
Patient Preference and Adherence
Basem Al-Omari 1 
Peter McMeekin2 
Angela Bate2
1College of Medicine and Health 
Sciences, Khalifa University, Abu Dhabi, 
United Arab Emirates; 2School of Health 
and Life Science, University of 
Northumbria, Newcastle-Upon-Tyne, UK 
Background: The use of conjoint analysis (CA) to elicit patients’ preferences for osteoar-
thritis (OA) treatment has the potential to contribute to tailoring treatments and enhancing 
patients’ compliance and adherence. This review's main aim was to identify and summarise 
the evidence that used conjoint analysis techniques to quantify patient preferences for OA 
treatments.
Methods: A comprehensive search strategy was conducted using electronic databases and 
hand reference checks. Databases were searched from their inception until 10th June 2019. 
All OA and CA related terms were used to conduct the search. The authors reviewed the 
papers and used the International Society of Pharmacoeconomics and Outcomes Research 
(ISPOR) checklist to assess the quality of the included studies.
Results: The search identified 534 records. Sixteen records were selected for full-text review 
and quality assessment and all were included in the narrative data synthesis. All included 
studies suggested that the severity of symptoms influenced the patients’ preference for OA 
treatment. All included studies recognised CA as a useful method to investigate patients’ 
preferences concerning OA treatment.
Conclusion: Patients preference for OA treatment is driven by the severity of patients’ 
symptoms and the desire to avoid treatment side effects and CA is a useful tool to investigate 
patients’ preferences for OA treatment.
Keywords: patient preferences, osteoarthritis, conjoint analysis
Background
Osteoarthritis (OA) is the most common form of arthritis.1 It is a long-term chronic 
disabling degenerative joint disease that causes pain and limitation of movement.2,3 
Pain associated with OA substantially reduces the patient’s mobility and quality of 
life.4 Treatments primarily target joint pain to maintain and improve joint mobility.5 
Options include surgery, pharmacological and non-pharmacological treatments.6,7 
However, alternative treatments differ in terms of the risks and benefits offered. 
Preferences for alternative treatments vary across individuals and depend on how 
they value the benefits relative to the associated risks.8,9
It has increasingly become the goal of healthcare systems to promote patient 
involvement,10 especially that the discordant patient and healthcare provider pre-
ferences for different attributes of healthcare interventions are common.11 In the 
United Kingdom (UK), the Health and Social Care Act 2012 made clear the duties 
of the national health service (NHS) to involve patients in the decisions about their 
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treatment.12 The use of stated preference techniques to 
elicit and understand patients’ preferences and values for 
health services and treatments to then inform treatment 
decisions is an accepted method of promoting patient- 
centred care13–15 and its use has grown dramatically.16–18 
Specifically, identifying patients’ preferences for OA treat-
ment offers a potential method for tailoring treatments, 
enhancing compliance, and improving patients’ 
satisfaction.19
One of the commonly used stated preference methods 
is conjoint analysis (CA)20,21 which is a popular analy-
tical technique for eliciting preferences.22 The idea 
behind CA is that it closely resembles the decisions 
that individuals make daily when choosing between 
multi-attribute alternatives.23 The popularity of CA in 
health care is growing and it has gained increasing 
attention in health services research.24,25 It is used as 
a method to measure patient preferences for health care 
and medicine, and as a means to identify and evaluate 
the relative importance of aspects of health outcomes 
and healthcare services.26,27 CA methods and particu-
larly discrete-choice experiments (DCEs) have become 
the most frequently applied approach in health care in 
recent years.28 A review of published studies using 
DCEs to quantify preferences in healthcare reported 
that their use increased from fewer than 20 per year on 
average in the 1990s to over 60 published per year 
between January 2013 and December 2017.29 Whilst 
DCEs are not the only conjoint analysis method, they 
make up the majority of published stated preference 
studies in healthcare.29 Other CA techniques include 
traditional choice based conjoint (CBC), best-worst scal-
ing (BWS), adaptive conjoint analysis (ACA) and adap-
tive choice-based conjoint (ACBC). All techniques 
require participants to compare and make trade-offs 
between a set of attributes and levels that define the 
health service or treatment under evaluation, and the 
trade-offs that participants make between these.30
Alongside the increasing use of CA techniques, 
increased attention has been paid to their methodological 
quality. In 2011 and prior to the Health and Social Care 
Act of (2012), the International Society of 
Pharmacoeconomics and Outcomes Research (ISPOR) 
published a checklist for good research practices for CA 
studies, highlighting the items to be considered for best 
practice for CA applications in healthcare studies.26
This systematic review aims to identify, summarise, 
and assess the methodological quality of the evidence 
that used CA techniques to quantify patient preferences 
for OA treatments and identify common approaches and 
methods employed and attributes considered important in 
eliciting patients’ preferences regarding OA treatment.
Methods
Search Strategy
A comprehensive search strategy was developed by the 
lead author. The Cochrane Library, PubMed (MEDLINE), 
CINHAL, EMBASE, and web of science were electroni-
cally searched from their inception until 10th June 2019. 
Medical Subject Headings (MeSH) and search terms were 
used to interrogate the databases. OA and CA related 
terms were used to conduct the search. No restrictions on 
publication language were used in the search strategy 
(appendix 1 shows an example of a MEDLINE search). 
In addition, electronic searching of Google, hand search-
ing through an examination of the reference list of the 
published articles and contact with experts were also 
used to identify additional publications.
Three authors reviewed the titles and abstracts and eval-
uated all records against the inclusion/exclusion criteria.
Inclusion Criteria
Studies included in the review fulfilled the following cri-
teria: 1) used any conjoint analysis methodology to elicit 
patient preferences including Conjoint Value Analysis 
(CVA), Choice-Based Conjoint (CBC), Discrete Choice 
Experiments (DCE), Best-Worst Scale (BWS), Adaptive 
Conjoint Analysis (ACA) and Adaptive Choice-Based 
Conjoint (ACBC); 2) focussed on patients diagnosed 
with OA irrespective of their age, gender, illness severity 
or joint of the body affected; 3) considered any form of 
OA intervention treatment.
Exclusion Criteria
Studies were excluded from the review if 1) participants 
were clinicians or healthcare workers (ie, not patients); 2) 
the focus was on the economic evaluation or willingness to 
pay (WTP) of a service or intervention; 3) the evaluation 
was restricted to quality rather than effectiveness or patient 
preference; 4) the focus was on the priority of treatment 
allocation, such as prioritising patients on the waiting list.
Quality Assessment and Data Extraction
The included papers were quality assessed and the data 
were extracted by the three authors. The ISPOR checklist 
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for CA26 was adopted to review and assess the methodo-
logical quality of studies included in this review. In the 
absence of a validated tool for quality assessment of CA 
studies, we considered the use of ISPOR checklist to guide 
this process. The checklist contains 10 main questions, 
each has 3 sub-questions, which adds up to 30 items in 
total.26 Studies were assigned a score of “1” for each item 
of the ISPOR checklist if they were considered to meet at 
least one aspect of this item and “0” if not. A total score 
for each study was calculated by summing the item scores. 
The maximum possible final score was 30.
A data extraction form was developed by two authors. 
Key data elements included: study aims, population char-
acteristics (country, number, age, and gender), sampling 
method, response rate, CA method, inclusion criteria, 
treatment, attributes, levels, and scenarios, statistical ana-
lysis, main results, and authors’ conclusion.
The included papers were independently assessed and 
scored by at least two of the three authors. Where there 
was a conflict of interest or potential reviewer bias, the 
reviewer in question was not involved in the assessment of 
scoring or the data extraction. Disagreements were 
resolved by discussion and consensus between all authors. 
A narrative data synthesis approach was used to analyse 
and report the results from the studies reviewed.
Results
Studies Identified
The search identified 534 records. Three hundred and 
sixteen records remained after removing duplicates. 
Based on the titles/abstracts review, a total of 297 records 
were deemed irrelevant and excluded as they did not meet 
one or more of the inclusion criteria. A further three 
records were excluded as they were published as confer-
ences proceeding abstracts and the full reports were not 
published and not available from the authors. The remain-
ing sixteen records were selected for full-text review and 
quality assessment. The PRISMA flowchart illustrating 
this process (see Figure 1).
Quality Assessment
Sixteen studies were included in the review. The quality 
assessment scores of studies ranged between 19/30 and 29/ 
30. This indicates that these studies fulfil at least 19 of the 
30 best practice criteria in the ISPOR checklist. Across the 
16 studies, there was low variation in total and individual 
item scores. Furthermore, the checklist did not provide 
emphasis to the themes that may have not been considered 
in the studies, which resulted in a high level of subjectivity 
in relation to the judgments made regarding the individual 
and total scores. Therefore, we are unable to make judg-
ments on the quality of the studies or discriminate based 
these scores.
Study Population, Sample Size and 
Recruitment
All the included studies expressed a clearly defined research 
aim and conducted original research to examine patients’ 
preferences comparing OA treatments (exercise, drug, or 
surgery), and presented testable hypotheses (see Table 1).
Fifteen studies were conducted in a single country 
site – one in Australia, five in the UK, and nine in the 
United States of America (USA). One study was con-
ducted across multiple countries – Australia, Canada, the 
UK, and the USA. Sample sizes for the studies ranged 
from 11 in the pilot study31 to 3895 the multi-site study.32 
Justifications for the sample sizes were based on the study 
type (eg, whether it was a pilot study or part of a larger 
trial) and the sampling strategies employed. Most studies 
recruited patient participants from clinical lists directly 
using letters, telephone interviews or face-to-face methods. 
Four studies sampled members of the general population 
via emails through market research databases to recruit 
participants who self-identified as living with OA. One 
study recruited participants from both clinical lists – the 
patient sample; and a random public sample (identified 
through random-digit telephone dialling).23 One study 
recruited participants from a clinical trial as part of the 
evaluation33 (see Table 2).
All studies included participants with OA, mean age 55 
years or more, and reported higher numbers of females to 
males. One study included a public sample of people age 20 
and over.23 One study did not report the gender of their 
population.19 The response rates (RR) reported varying from 
7.6%32 to 100%9,31,34,35 in the included studies, population and 
sampling features are presented in Table 2. The methods of 
data collection used in the studies also vary, reporting mostly 
either computer-based questionnaire,9,31,34–40 or online web- 
based questionnaires32,40,41 (see Table 2).
Conjoint Analysis Method
A range of CA methods was used in the included studies. 
One study used Conjoint Value Analysis (CVA), three studies 
used Choice-Based Conjoint (CBC), three studies used 
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Discrete Choice Experiments (DCE), three studies used 
Adaptive Choice-Based Conjoint (ACBC), and six studies 
used Adaptive Conjoint Analysis (ACA) (see Table 3). The 
number of attributes and levels identified in the studies 
ranged from 4 attributes with 12 levels35 to 9 attributes 
with 29 levels41 (see Table 3). The attributes tended to define 
the features of the OA symptoms, OA treatment such as the 
benefits and the risks, and cost of treatment (for all attributes 
and levels of the included studies see appendix 2).
Statistical Analysis
In all types of CA, regression analysis techniques are gen-
erally used to study the patient’s preference. The choice of 
regression analysis type in CA depends on the type of the 
main outcome under study (eg, binary outcome, continuous 
outcome, etc.). More recent studies have adopted 
Hierarchical Bayesian (HB) models to investigate partici-
pants’ preferences at both the group “average” level as well 
as at the individual level31,35,41 (see Table 3).
Figure 1 The PRISMA flowchart. 
Notes: Adapted from Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The 
PRISMA Statement. PLoS Med. 2009;6(7):e1000097. © 2009 Moher et al. Creative Commons.54
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Table 1 Type of OA Treatment, Aims, and Findings for All Reviewed Studies
Study OA Treatment Aims Findings
Al-Omari, (2017)31 Pharmaceutical treatment The aim of the present study was to 
evaluate the use of ACBC in eliciting 
treatment preferences by determining the 
relative importance of 8 attributes in 
selecting pharmaceutical treatment of OA.
ACBC is a potentially valid method of 
evaluating patients’ preferences for 
pharmaceutical treatment of OA. The 
current findings indicate that OA patients 
are most concerned with the avoidance of 
adverse events and that there is a threshold 
above which expected benefit has little 
impact on patients’ medication preferences.
Al-Omari et al 
(2015)34
Pharmaceutical treatment The aim of this study was to examine the 
feasibility of ACBCA in patients with OA.
Adequate face and measurement validity of 
an ACBCA task can be achieved through 
a developmental process taking account of 
participants’ requirements. The involvement 
of participants during the design phase of the 
task enabled the research team to construct 
an ACBCA task that resulted in participants 
reporting that the task helped them to 
identify their medication preferences for the 
treatment of osteoarthritis.
Al-Omari et al 
(2017)9
Pharmaceutical treatment The aim of the current study was to 
investigate the potential of ACBC as an 
approach to supporting shared decision- 
making with individual patients in clinical 
practice.
Individual patients have preferences that are 
likely to lead to different medication choices. 
ACBC has the potential to identify individual 
preferences as a practical basis for concordant 
prescribing for osteoarthritis in clinical practice.
Byrne et al 
(2006)23
Total Knee Replacement Exploring ethnic differences in preferences 
for surgery in the context of knee OA and 
Total Knee Replacement (TKR).
Differences in knee replacement rates 
among ethnic groups could be partly due to 
differences in preferences for surgery. 
Conjoint analysis is a feasible methodology 
for collecting preferences in health research 
and it contribute to the decision-making 
process of health care practitioners.
Chang et al 
(2005)32
NSAIDs To describe the health state preferences of 
patients with OA according to their level of 
pain and disability and according to the 
extent of gastrointestinal side effects from 
NSAIDs.
Disease severity appeared to have a greater 
effect on ratings than did side effect severity, 
but we cannot conclude that patients value 
disease severity more than side effect 
severity because these were not compared 
directly on the same scale.
Fraenkel et al 
(2004A)37




To examine whether the current widespread 
use of anti-inflammatory drugs may reflect 
a lack of informed choice among older 
patients with knee osteoarthritis (OA).
When evaluating multiple alternatives, many 
older patients with knee osteoarthritis are 
willing to forgo treatment effectiveness for 
a lower risk of adverse effects.
Fraenkel et al 
(2004B)38





Examine older patients’ treatment 
preferences for knee OA, determine the 
influence of specific medication 
characteristics on patients’ choices, and 
examine whether patients’ preferences are 
consistent with current practice.
Patients prefer the less effective but safer 
choice of treatment. The widespread use of 
anti-inflammatory drugs may, in part, reflect 
lack of informed choice among older 
patients with OA. Health care providers 
should encourage patient participation in 
decision-making to ensure informed choice 
among older adults with arthritis.
(Continued)
Patient Preference and Adherence 2021:15                                                                               submit your manuscript | www.dovepress.com                                                                                                                                                                                                                       
DovePress                                                                                                                         
201




































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Table 1 (Continued). 
Study OA Treatment Aims Findings
Fraenkel et al 
(2004C)36





To test whether the widespread use of 
cyclooxygenase-2 (COX-2) inhibitors may 
be mediated in part by a perception that 
COX-2 inhibitors eliminate the risk of 
serious gastrointestinal (GI) events in 
contrast to merely reduce their risk.
OA patients’ preferences for COX-2 
inhibitors over NSAID are strongly 
influenced by the appeal of zero risk of side 
effects. The willingness shown by older 
adults to pay for COX-2 inhibitors may 
reflect a misperception of the risk of toxicity 
associated with these medications.




Intra-articular (IA) Injections. 
Exercise.
To examine patient preferences for exercise 
in comparison to other osteoarthritis 
treatment options.
Patients preferred exercise over other 
treatment options, whether intra-articular 
injections or NSAIDs were 20% or 50% 
more effective at decreasing symptoms 
compared to other options. The relative 
importance assigned to treatment benefits 
and risks were 29% and 41% respectively.
Fraenkel et al 
(2014)35
Disease modifying drugs for 
osteoarthritis (DMOADs)
The objectives of this study were to 1) 
quantify patient preferences for hypothetical 
DMOADs over a specified range of risks, 
benefits and costs using conjoint analysis 
and 2) determine the added value of latent 
class segmentation analysis in understanding 
the breadth of patients’ perspectives.
Many patients might be willing to accept 
some degree of risk to prevent worsening 
knee OA.




To compare preferences for arthroplasty 
versus arthrodesis in patients with proximal 
interphalangeal joint osteoarthritis.
Joint stiffness and grip strength emerged as 
the leading patient preference drivers, need 
for future surgery and cost were moderate 
influencing factors, and recovery time 
proved to be least important. Offering 
arthroplasty as the first-line surgical option 
is a highly patient-centered approach.
Hauber et al 
(2013)39
NSAIDs and selective COX- 
2 inhibitors.
To estimate OA patients’ risk tolerance for 
serious adverse events including bleeding 
ulcer, MI, and stroke.
Patients generally attached greater 
importance to eliminating the risks of 
adverse events than in reducing pain.
Laba et al (2013)33 Pharmaceutical To estimate the relative influence 
of medication-related factors and respondent 
characteristics on decisions to continue 
medications among people with symptomatic 
OA.
Medication risks and cost were important 
and ought to be borne into considerations in 
interpreting clinical trial evidence for 
practice.
Moorman et al 
(2017)41
Surgical To obtain patient-preference evidence to 
inform regulatory approval decisions by the 
Food and Drug Administration (FDA) 
Center for Devices and Radiological Health 
during the benefit-risk assessment of 
surgical interventions for knee OA.
Stated patient preferences suggested that 
patients with knee OA, particularly younger 
patients with higher levels of pain and 
functional restrictions, would prefer 
a surgery that does not require bone cutting 
or removal.
(Continued)
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Treatment Preferences
The review included studies investigating pharmaceutical, 
non-pharmaceutical, and surgical treatment for OA (see 
Table 1).
NSAID and Other Medication Treatment
The majority of studies investigated the side effects and 
other features of nonsteroidal anti-inflammatory drugs 
(NSAIDs) and other medications such as disease- 
modifying drugs and supplements (glucosamine) on 
patients’ preferences for treatment of OA.9,32,33,35–39,41–43
The relative importance of the risks of side effects; 
both rare and common were rated more important than 
the benefits associated with the treatment, time to benefit, 
out-of-pocket monthly cost, route of administration, and 
the product label.36–38 One study found that relatively the 
most important attribute was the route of administration 
(cream, pills, injections into the knee and exercise) (rela-
tive importance of 24%), followed by the risk of dyspepsia 
and risk of bleeding ulcer, with the least important being 
decrease in pain and improved strength (relative impor-
tance of approximately 14%).42 Similarly, a study investi-
gating the long-term evaluation of glucosamine sulphate, 
found that relatively the most important attributes were the 
side effects of high blood pressure, heart/liver/kidney pro-
blems followed by cost.33 The authors concluded that in 
their study, preferences to continue with OA treatments 
were influenced by side effects first and foremost and 
treatment efficacy did not significantly influence patient 
choice.33 Again, a study31 investigating 8 medication attri-
butes, found that relatively the risks of side effects were 
the most important (combined their relative importance 
accounted for 66% of the treatment decision) and effec-
tiveness of the medication only accounted for 8% of the 
treatment decision.
Exercise Treatment
One study examined patients’ preferences for exercise in 
the context of other available treatment options (excluding 
surgery).42 The authors found that patients prefer exercise 
over pharmacological treatment for; risk of dyspepsia and 
bleeding ulcer combined accounted for the relative impor-
tance of 41.3% compared to 28.9% relative importance for 
both decrease pain and improve strength attributes.42 
Another study investigated individual preferences for phy-
sical activity attributes (with no comparison to other types 
Table 1 (Continued). 
Study OA Treatment Aims Findings
Pinto et al (2019)40 Physical Activity preferences 
(PA)
To investigate individual preferences for PA 
attributes in adults with chronic knee pain, 
to identify clusters of individuals with similar 
preferences, and to identify whether 
individuals in these clusters differ by their 
demographic and health characteristics.
Patients with chronic knee pain have 
preferences for PA that can be distinguished 
effectively using ACA methods. Adults with 
chronic knee pain, clustered by PA preferences, 
share distinguishing characteristics. 
Understanding preferences may help clinicians 
and researchers to better tailor PA 
interventions.
Ratcliffe et al 
(2004)43
NSAIDs To investigate the patient preferences for 
attributes associated with the efficacy and 
side-effects of treatment for osteoarthritis.
Respondents were relatively more 
concerned about the risk of serious side 
effects (even with a very low probability) 
than mild to moderate side effects (at 
a much higher probability). Older 
respondents were more willing than 
younger respondents to accept an increased 
risk of experiencing serious side effects for 
an improvement in the symptoms of 
osteoarthritis. The use of conjoint analysis 
to assess patient preferences provides 
a useful insight to the likely attitudes of 
patients to novel treatments for 
osteoarthritis.
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Table 2 Sampling for All Reviewed Studies
Study Country Sample 
Size
RR Sampling Method Inclusion Criteria
Al-Omari, 
(2017)31
UK 11 100% Participants were drawn from members of 
a Research Users’ Group (RUG).
Had been diagnosed with OA and had 
reported one or more of hip, knee, hand 
and foot joint pain in the past 12 months.
Al-Omari et al 
(2015)34
UK 11 100% Members of a research users’ group 
(RUG) in a research centre who have 
osteoarthritis were contacted by 
telephone and invited to attend one group 
session.
Participants who were representative of 
potential users of the software for 
discrete choice experiments and shared 
decision-making regarding OA medication 
in clinical practice. 
All participants were diagnosed with 
osteoarthritis and reported experiencing 
one or more of hip, knee, hand, or foot 
joint pain in the past 12 months.
Al-Omari et al 
(2017)9
UK 11 100% Random selection from members of 
a research users’ group (RUG) in 
a research centre.
Not previously involved in design of 
ACBA task. with osteoarthritis and 
reporting one or more of hip, knee, hand, 
and foot joint pain over the previous 12 
months.









Public sample: Random-digit-dialing list of 
4000 telephone numbers 
Patient sample: list of 1286 patients from 
Kelsey Seybold clinics.
Public sample: Adults living in Houston, 
age 20 or older 
Patient sample: Patients treated for knee 
osteoarthritis, age 55 to 80.







3895 7.6% of 
the total 
invitation
Distributed 57,452 invitations by email 
using Harris Interactive. Harris Interactive 
is a website for methods and tools of 
market research (Harris Interactive, 
2010).
Osteoarthritis patients who provided 
consistent ratings to the benchmark rating 
scenarios.
Fraenkel et al 
(2004 A)37
USA 100 84% Patients were sent a letter describing the 
study and then contacted by telephone 1 
week later.
Osteoarthritis patients having pain in one 
or both knees on most days of the month 
and not having rheumatoid arthritis, gout, 
pseudogout, or bilateral knee 
replacements.
Fraenkel et al 
(2004 B)38
USA 100 84% Patients were sent a letter describing the 
study and then contacted by telephone 1 
week later.
Osteoarthritis patients having pain in one 
or both knees on most days of the month 
and not having rheumatoid arthritis, gout, 
pseudogout, or bilateral knee 
replacements.
Fraenkel et al 
(2004 C)36
USA 100 84% Patients were sent a letter describing the 
study and then contacted by telephone 1 
week later.
Osteoarthritis patients having pain in one 
or both knees on most days of the month 
and not having rheumatoid arthritis, gout, 




USA 90 78.9% A research assistant recruited participants 
by approaching patients waiting in the 
primary care waiting room area.
Patients over 60 years of age, reporting 
pain in one or both knees on most days of 
the month, able to read and understand 
English, and able to perform a choice task.
(Continued)
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Table 2 (Continued). 
Study Country Sample 
Size
RR Sampling Method Inclusion Criteria
Fraenkel et al 
(2014)34
USA 304 100% Convenience sample Patients attending general medicine and 
subspecialty outpatient clinics affiliated 
with a large university medical centre.
Harris et al 
(2018)44
USA 404 49.5 Respondents were recruited via e-mail 
invitation from Harris Interactive’s 
(Rochester, New York, USA) online 
chronic-illness, panel in the UK.
Participating patients were required to 
have a self-reported physician’s diagnosis 
of OA and to be a UK resident aged 45 
years or older.
Hauber et al 
(2013)39
UK 289 98% Respondents were recruited via e-mail 
invitation from Harris Interactive’s 
(Rochester, New York, USA) online 
chronic-illness panel in the UK.
Participating patients were required to 
have a self-reported physician’s diagnosis 
of OA and to be a UK resident aged 45 
years or older.
Laba et al 
(2013)33
Australia 188 37% A paper-based survey was given to all 
LEGS (Long-term Evaluation of 
Glucosamine Sulfate study - a two-year, 
double-blind, placebo-controlled 
randomised clinical trial) participants 
attending their end-of-study visit by 
a member of the LEGS research team; 
surveys were mailed to participants who 
had already completed end-of-study visits.
All LEGS participants completing their 
end-of-study visit were eligible to 
participate.
Moorman et al 
(2017)41
USA 323 81.8% An email invitation to the survey was sent 
in June 2016 to a group of Internet 
panelists in the United States. They were 
recruited from Research Now, an online 
sampling and data collection company that 
provides a nationally representative panel 
of consumers.
Men and women aged 25 to 80 years; 
Diagnosed with OA in the knee; 
Experience pain in the knee of ≥4 on a 0 
to 10 scale, where 0 means not at all 
painful and 10 means extremely painful; 
Experience knee pain at least once a week; 
Previously failed nonsurgical treatments 
for knee OA pain; Pass a security screen; 
No previous surgical implant involving the 
knee (ie TKA, UKA).
Pinto et al 
(2019)40
USA 150 97.3 Participants were recruited at community 
senior centers and resource fairs and from 
general internal medicine clinics at 
Northwestern Medicine, the Shirley Ryan 
AbilityLab (formerly the Rehabilitation 
Institute of Chicago) and via flyers posted 
on the Northwestern University medical 
campus, Chicago, USA.
Participants self-reported knee pain, ache 
or stiffness on most days of at least 1 
month during the last year, were at least 
45 years old, expressed interest in 
increasing or maintaining PA, and had no 
prior history of knee replacement on the 
side of complaint. Participants underwent 
a standing, fixed-flexion knee X-ray to 
identify presence of KOA.








The general population sample of 
respondents aged 55 years and over was 
identified using a market research 
database. The respondents answered 
a recruitment questionnaire over the 
phone.
Patients living with osteoarthritis over 55 
years of age.
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Al-Omari, (2017)31 ACBC 8/28 Not reported Hierarchical Bayes
Al-Omari et al 
(2015)34
ACBC 8/28 Not reported Not reported
Al-Omari et al 
(2017)9
ACBC 8/28 Variable Monotone regression
Byrne et al 
(2006)23
CBC 6/17 36 paired choices divided into 6 sets of 6 
paired scenarios and each participant was 
randomly assigned to one of the 6 sets.
Logistic regression analysis
Chang et al 
(2005)32
CVA 6/31 25 OA health state–side effect scenarios 
related to NSAIDs
Multivariable regression analysis
Fraenkel et al 
(2004A)37
ACA 7/27 Not reported Least squares regression analysis
Fraenkel et al 
(2004B)38
ACA 7/27 Not reported Least squares regression analysis
Fraenkel et al 
(2004C)36
ACA 7/27 Not reported Least squares regression analysis
Fraenkel and Fried, 
(2008)42
ACA 5/13 Not reported Least squares regression analysis
Fraenkel et al 
(2014)35
CBC 4/12 12 Hierarchical Bayes (HB) modelling. Subsequently 
performed Latent Class analysis to examine 
whether preferences clustered by specific 
segments.
Harris et al 
(2018)44
DCE 5/12 72 Individual pooled aggregate logit (Empirical Bayes 
& MLE)
Hauber et al 
(2013)39
DCE 6/24 30, split across 3 questionnaires Random parameters logit model. All analyses 
were conducted using NLOGIT 4.0.
Laba et al (2013)33 DCE 7/20 16 For the choice data, a panel mixed multinomial 
(random parameters) logit (MMNL) model was 
used to investigate changes in utility (U) (ie 
preference to continue taking a medication) 
when the level of a factor was changed using 
NLOGIT Version 4.0.
Moorman et al 
(2017)41
CBC 9/29 12 A hierarchical Bayesian multinomial logit model 
was used to generate utilities that accounted for 
individual preferences.
Pinto et al (2019)40 ACA 6/18 On average 35 The PAPRIKA method was used to estimate 
‘Part-worth utilities’ (weights) representing the 
relative importance of the attributes.
Ratcliffe et al 
(2004)43
DCE 5/15 16 paired choices divided into 3 sets of 8 
paired scenarios and each participant was 
randomly assigned to one of the 3 sets.
Random effects probit regression model
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of OA treatment).40 This study found that “health benefits” 
(26%) and “enjoyment” (24%) attributes were considered 
by patients to be relatively the most important.
Surgical Treatment
Three studies investigated patients’ preferences for surgi-
cal treatment of OA. One study investigated the relative 
preferences for 9 different surgical related procedure attri-
butes and simulated how patients may have responded to 
real-world knee OA procedures based on their 
preferences.41 They found that patient preferences for sur-
gical interventions were influenced by “the amount of 
cutting and removal of existing bone required” (relative 
importance of 18.7%), followed by “chance of additional 
surgery” (relative importance of 14.1), “amount of pain 
relief” (relative importance of 12.7%), with the least 
important attributes being “limits or complicates any 
future treatment need on the knee” and” length of hospital 
stay” with a relative importance of 7.3% each.41
Similarly, in the study comparing patient preferences 
for surgery for patients with a hand OA diagnosis,44 the 
authors found that “the need for future surgery” (relative 
importance=19%) and “recovery time” (relative impor-
tance=3%) were the least important factors influencing 
surgical preferences, while “joint stiffness” (relative 
importance=32%) and “grip strength” (relative impor-
tance=29%) were the most important. This supports the 
results from the earlier study that explored preferences for 
surgery versus medical treatment of knee OA,23 which 
found that the severity of OA symptoms, directly and 
indirectly, influenced the patients’ choice of OA treatment, 
even in the presence of cultural differences in attitudes 
towards particular treatments.
Discussion
To the best of our knowledge, this is the first review to 
investigate and summarise the use of CA techniques to 
value patients’ preferences for OA treatment. In addition, 
the search strategy was comprehensive, including the 
search of many databases, contacting authors and experts 
in the field, and searching the reference lists of published 
studies.
One of the limitations of this review is the lack of 
a validated quality assessment tool for CA studies. The 
use of the ISPOR checklist to score studies may be sub-
jective to the examiner’s opinion. We tried to assess the 
methodological quality of these studies using the ISPOR 
Conjoint Analysis Experimental Design Good Research 
Practices Checklist. We were unable to make an objective 
decision regarding the minimum acceptable evidence 
required to award the scores. For example, question 2 
“was the choice of attributes and levels supported by 
evidence?” we were unable to determine the quality and 
quantity of evidence required. This caused lengthy subjec-
tive disputes between the reviewers. Furthermore, the total 
scores for the studies indicated that CA studies published 
post the publication of the ISPOR checklist scored higher 
than those published pre-2011. This would be expected as 
most of these studies referenced ISPOR in their papers, 
meaning that we are assessing their quality against the 
same or similar criteria they used to design their studies, 
which was not available for studies published before 2011. 
It is not clear if this improvement in the scores is corre-
lated with the publication of the ISPOR checklist or is 
simply reflecting an improvement in reporting. We agree 
with Webb and colleagues that the ISPOR checklist should 
not be used as a quality assessment tool for conjoint 
studies in its current format, as it was not originally 
developed for this purpose.45
The studies have a high degree of heterogeneity in 
study design, study population, and treatment choice. The 
included papers incorporated studies using both rating/ 
ranking and choice-based methods to investigate different 
options of treatment for OA (exercise, medication, and 
surgery) in the UK, Australia, Canada, and the USA. All 
included studies had homogeneous samples in terms of 
suffering from OA. Thus, the studies sample may repre-
sent the OA population. However, the healthcare systems 
differ between the countries within which the studies were 
conducted; therefore, the generalisability of the results 
could be limited.
Variations in the sample sizes between included studies 
(n = 11 to 3895) may indicate that there is still no con-
sensus on the appropriate or agreed sample size calculation 
method for CA studies, as it depends on many factors such 
as the number of questions and scenarios in the conjoint 
task. It has been suggested that the sample size for a CA 
study should be at least 300 in one sample group.46 
However, the traditional calculations for sample size deter-
mination cannot readily be applied to CA43 and are rarely 
applied for practical reasons.47 Furthermore, it has been 
argued that collecting more data from each respondent by 
designing high-quality conjoint tasks may reduce sampling 
and measurement error.46 Using similar CA methods to 
those in the review36–38,42 in a study of patient preferences 
for acute pain treatment researchers attempted to reduce 
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the limitation of a small sample (50 participants) by inter-
viewing their respondents 4 times at 4 different stages of 
pain treatment.48 Limitations around sample size in CA 
studies may be overcome in the design of the conjoint task 
and data collection.
The variation in the RR (7.6% to 100%) in the studies 
is potentially a reflection of the robustness of the methods 
of recruitment and methods of data collection. The 
included studies used a variety of methods of data collec-
tion. Methods reporting face-to-face interviewing or ques-
tionnaires targeted a specific population of interest tended 
to have higher response rates. Studies using telephone 
interviewing or emails, predominantly in a general popula-
tion, had a lower response rate. These studies with low RR 
recognised the limitations of using an untargeted strategy 
and suggested response rates could be improved in future 
research by pre-screening participants in order to target the 
full survey to those who report a diagnosis or other study 
characteristic of interest.32
All included studies recognised the value in utilising 
CA method to investigate patients’ preferences for OA 
treatment, but there was no consensus on which CA 
approach is the most appropriate. Both rating/ranking and 
choice-based methods were used to examine patients’ pre-
ferences for the treatment of OA. Recent academic and 
practical research applications have tended to favour 
choice-based approaches as opposed to rating/ranking.49 
However, the rating/ranking approach has also been used 
and recommended by many researchers to study patients’ 
preferences for OA treatment36–38,42 as well as treatment 
preferences in rheumatoid arthritis (RA),50 chronic pain,51 
and abdominal surgery48 because it allows the inclusion of 
a large number of attributes and levels, which reflect the 
outcomes/concerns of patients with OA. The main advan-
tage of ACA is that it is adaptive and therefore allows 
a large number of characteristics to be evaluated without 
resulting in information overload or respondent fatigue, 
and minimises interviewer, product, and brand bias. 
Nevertheless, there are still practical limitations associated 
with ACA, with researchers reporting that not all treatment 
characteristics could be included in an ACA task.36–38
In this review, studies that used the choice-based 
approach reported that the use of the discrete choice 
method allowed them to identify attributes significantly 
influencing patients’ preferences for OA treatment.43 
Furthermore, a very low number of inconsistent responses 
were found, and participants reported that the questions 
were easy or very easy to answer.23 Those studies that 
used ACBC9,31,34 argued that the approach can capture 
more individual-level data and precise estimates than 
through a traditional CBC approach and that it can yield 
similar group-level standard errors using up to 38% fewer 
participants.39,40 Furthermore, it has been reported that the 
ACBC method is more user friendly and engaging than 
alternative CA methods31,34,52,53 and it can be used to 
elicit individual patients’ preferences.9
Overwhelmingly the results of the studies in this 
review indicated that patient preferences for OA medica-
tions were driven by the desire to avoid both common and 
rare side effects, especially those with more serious drug- 
related toxic effects and that the effectiveness of the OA 
medication had very little impact on patients’ preferences. 
However, where investigated, studies suggested that pre-
ferences for side effects were affected by patient charac-
teristics such as age and symptoms severity. Older 
respondents were more willing than younger respondents 
to trade-off an increased risk in the side effects36–38,43 for 
an improvement in the symptoms of OA. The side effects 
associated with NSAIDs had a greater negative influence 
on the preferences of patients with milder OA than those 
in more severe OA states.32 Even when exercise was 
compared to OA medications, patients were still more 
concerned about the side effects of the treatment than the 
benefits.42 However, patients with more knee pain were 
more reluctant to choose exercise.
Patients generally attached greater importance to redu-
cing or eliminating adverse events than reducing pain, but 
one study investigated the level of treatment-related risks 
patients were willing to accept in exchange for various 
improvements in pain.39 The investigators found that par-
ticipants’ “risk tolerance” varied according to their pain 
level at baseline and type of symptom relief – participants 
were willing to accept greater risks for improvements in 
ambulatory pain than in resting pain.39 Similarly, a study 
of treatment options for disease-modifying drugs found 
that sub-groups of participants were willing to trade-off 
the risks of side-effects for improvements in a benefit.35 In 
relation to surgical treatment for OA, it was reported that 
younger patients and those who reported the highest pain 
thresholds, and the greatest functional limitations were 
more likely to opt for surgical intervention.41 
Furthermore, the severity of the patients underlying symp-
toms proved to be the main driver influencing their pre-
ferences for surgery.44
Where the severity of OA symptoms was measured 
alongside the conjoint task, all included studies suggested 
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that the severity of symptoms influenced the patients’ 
preference of treatment, and consequently the relative 
importance of treatment characteristics. However, it is 
not clear whether these differences are a result of symptom 
severity or artefacts of the CA methods, attributes used, or 
treatments being assessed.
Conclusion
The severity of OA symptoms and the side effects of 
treatment have a significant influence on patients’ pre-
ferences for OA treatment. Both rating/ranking and 
choice-based CA methods are recommended in investi-
gating patients’ preferences for OA treatment, but there 
is no consensus on which CA approach is the most 
appropriate.
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